- Announced the appointment of Joseph Braganza to the role of Senior Vice President, Head of M&A.
- Mr. Braganza joins the senior leadership team with a mandate to lead Novamind’s M&A strategy, accelerating the Company’s expansion plans for its network of clinics, retreats and clinical research sites.
TORONTO, ON / March 3, 2021 / Novamind Inc.,(CSE:NM)(OTC PINK:NVMDF) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, announces the appointment of Joseph Braganza to the role of Senior Vice President, Head of M&A. Mr. Braganza joins the senior leadership team with a mandate to lead Novamind’s M&A strategy, accelerating the Company’s expansion plans for its network of clinics, retreats and clinical research sites.
Joseph has gained tenure as a M&A specialist and strategist, building sustainable programmatic M&A approaches for high-growth organizations. Leveraging over 20 years of professional experience, Joseph recently led the M&A group as Vice President, Business and Corporate Development at Canadian Addiction Treatment Centres (CATC), a consolidator of outpatient addiction treatment clinics that currently operates over 70 clinics and an inpatient residential treatment facility. Joseph previously held senior M&A roles at People Corp. (acquired by Goldman Sachs Merchant Banking), Rexall Health Solutions (a subsidiary of McKesson Corp.) and Deloitte.
“I am deeply committed to Novamind’s vision to scale their operating model for psychedelic medicine,” Braganza commented. “Facilitating greater access to these breakthrough treatments is critical in helping people find new ways to improve their mental health. I look forward to working with the leadership team as we pursue Novamind’s vision.”
Yaron Conforti, CEO and Director of Novamind added, “We’re excited to announce Joseph’s appointment to lead our M&A team. Joseph’s experience acquiring and integrating businesses, combined with his expertise in the mental health sector make him uniquely positioned to contribute to Novamind’s strategic growth plans.”
Read More: https://agoracom.com/ir/Novamind/forums/discussion/topics/756466-novamind-expands-leadership-team-accelerating-m-a/messages/2306202#message
Tags: COMPASS PATHWAYS, CSE, Field Trip Health Ltd., MIND MEDICINE (MINDMED) INC, NUMINUS WELLNESS INC, Psychedelic